Προφιλ ιατρού

JOHANNA THERESE GUSTAFSSON
ΡΕΥΜΑΤΟΛΟΓΟΣ

MD PhD, ΕΠΙΣΤΗΜΟΝΙΚΗ ΣΥΝΕΡΓΑΤΗΣ

Εκπαίδευση & Ακαδημαϊκοί Τίτλοι
- 2017: Τίτλος Ιατρικής Ειδικότητας Ρευματολογίας, Αναγνώριση Τίτλου, 2009, Karolinska University Hospital, Διεύθυνσης Δημόσιας Υγείας Αττικής
- 2012: PhD Thesis in Rheumatology, Cardiovascular Disease in Systemic Lupus Erythematosus, Karolinska Institute, Stockholm, Sweden
- 2009: Specialist Degree in Rheumatology, Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden
- 2003: Rotational Training Scheme, Department of Rheumatology, Karolinska University Hospital
- 2000: Medical School, University of Gothenburg, Gothenburg, Sweden Degree in Medicine
Διδακτορική Διατριβή
- 2012: PhD Thesis in Rheumatology, Cardiovascular Disease in Systemic Lupus Erythematosus, Karolinska Institute, Stockholm, Sweden
Επαγγελματική Προϋπηρεσία
- Από το 2022: Ρευματολογικό Τμήμα, ΙΑΣΩ Γενική Κλινική
- 2017: Επιστημονική Συνεργάτιδα, Τμήμα Ρευματολογίας, Β Παθολογική Κλινική Ιατρικής Σχολής Ε.Κ.Π.Α., Ιπποκράτειο Νοσοκομείο, Αθήνα
- 2009: Consultant in Rheumatology, Responsible for Outpatient Clinic, Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden
- 2003: Senior House Officer in Rheumatology, Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden
Κλινικό Ενδιαφέρον
- Συστηματικός Ερυθηματώδης Λύκος
- Αγγειίτιδες
- Ρευματοειδής Αρθρίτιδα
Βραβεία & Διακρίσεις
- 2012: Pfizer Scholarship for young Researchers and the Scientific Research on immunological and genetic factors for the risk for development of Cardiovascular diseases in Systemic Lupus Erythematosus , SLE
- 2008, Prize for best abstract, Läkarstämman. Predictors of the first arterial event in patients with Systemic Lupus Erythematosus
Πρόσφατες Δημοσιεύσεις
- Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
  Elisabet Svenungsson, Johanna T Gustafsson, Giorgia Grosso, Marios Rossides, Iva Gunnarsson, Kerstin Jensen- Urstad,Anders Larsson, Kristina N Ekdahl, Bo Nilsson, Anders A Bengtsson, Christian Lood,
  Rheumatology (Oxford). 2020 Nov 1;59(11):3264-3274
- Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA- DRB1 Genotype Associations and Immunological and Clinical Manifestations
  Lina-Marcela Diaz-Gallo, Vilija Oke, Emeli Lundström, Kerstin Elvin, Yee Ling Wu, Susanna Eketjäll, Agneta Zickert, Johanna T Gustafsson, Andreas Jönsen, Dag Leonard, Daniel J Birmingham, Gunnel Nordmark, Anders A Bengtsson, Lars Rönnblom, Iva Gunnarsson, Chack-Yung Yu, Leonid Padyukov, Elisabet Svenungsson ACR Open Rheumatol 2022 Jan;4(1):27-39
- Predictors of the first cardiovascular event in patients with Systemic Lupus Erythematosus: A prospective cohort study
  Gustafsson J, Gunnarsson I, Jensen-Urstad K, Börjesson O, Pettersson S, Möller S, Guo-Zhong F , Hansson LO, Lundberg I, Larsson A, Svenungsson E. Arthritis Res Ther. 2009;11(6):R186
- A STAT4 risk allele is associated with ischemic cerebrovascular events and antiphospholipid antibodies in Systemic Lupus Erythematosus
  Svenungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, Jönsen A, Bengtsson A, Sturfelt G, Rantapää-Dahlqvist S, Elvin K, Sundin U, Garnier S, Sigurdsson S, Padyukov L, Syvänen A-C, Rönnblom L., Ann Rheum Dis. 2010;69(5):834-40
- Physical capacity and activity in patients with systemic lupus erythematosus and matched controls.
  Eriksson K, Svenungsson E, Karreskog H, Gunnarsson I, Gustafsson J, Möller S, Pettersson S, Boström C. Scand J Rheumatol. 2011;41(4):290-7
- Risk factors for cardiovascular mortality in Systemic Lupus Erythematosus, a prospective cohort study
  Gustafsson J, Simard J, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, Larsson A, Svenungsson E. Arthr Res Ther. 2012;14(2):R46
- HLA-DRB1*04/*13 alleles are associated with vascular disease and antiphospholipid antibodies in systemic lupus erythematosus
  Lundström E, Gustafsson JT, Jönsen A, Leonard D, Zickert A, Elvin K, Sturfelt G, Nordmark G, Bengtsson A, Sundin U, Källberg H, Sandling JK, Syvänen AC, Klareskog L, Gunnarsson I, Rönnblom L, Padyukov L, Svenungsson E. Ann. Rheum. Dis 2013 Jun;72(6):1018-25
- Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays. Vikerfors A, Johansson A-B, Gustafsson JT, Jönsen A, Leonad D, Zickert A, Nordmark G, Bengtsson A, Rönnblom L, Gunnarsson I, Elvin K, Svenungsson E. Rheumatology. 2013 Mar;52(3):501-9
- Autoantibodies to the functionally active RING-domain of Ro52/SSA associate with clinical activity in a subset of patients with lupus.
  Kvarnström M, Dzikaite V, Ottosson L, Gustafsson JT, Gunnarsson I, Svenungsson E, Wahren-Herlenius M. Lupus. 2013;22(5):477-85
- Coronary Heart Disease in Systemic Lupus Erythematosus is associated with interferon regulatory factor 8 gene variants.
  Leonard D, Svenungsson E, Sandling JK, Jönsen A, Bengtsson C, Wang C, Jensen-Urstad K, Bengtsson AA, Gustafsson JT, Gunnarsson I, Ortmann, W, Graham RR, Rantapää-Dahlqvist S, Nordmark G, Eloranta ML, Behrens TW, Syvänen AC, Rönnblom L. Circ Cardiovasc Genet. 2013 Jun;6(3):255-63
- Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
  Gustafsson JT, Svenungsson E. Autoimmunity. 2014 Mar;47(2):67-76
- Cigarette smoking, antiphospholipid antibodies and vascular events in Systemic Lupus Erythematosus
  Gustafsson JT, Gunnarsson I, Pettersson S, Zickert A, Vikerfors A, Möller S, Rönnelid J, Elvin K, Källberg H Svenungsson E. Ann. Rheum Dis 2015 Aug.;74(8):1537-43
- Increased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus
  Svenungsson E, Engelbertsen D, Wigren M, Gustafsson JT, Gunnarsson I, Elvin K, Jensen-Urstad K, Fredrikson GN, Nilsson J. Clin Exp Immunl 2015 Sep;181(3):417-26
- Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts.
  Jönsen A, Hjalte F, Willim M, Carlsson KS, Sjöwall C, Svenungsson E, Leonard D, Bengtsson C, Rantapää- Dahlqvist S, Pettersson S, Gunnarsson I, Zickert A, Gustafsson JT, Rönnblom L, Petersson IF, Bengtsson AA, Nived O.Semin Arthritis Rheum. 2016 Jun;45(6):684-90
- Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations.
  Mobarrez F, Vikerfors A, Gustafsson JT, Gunnarsson I, Zickert A, Larsson A, Pisetsky DS, Wallén H, Svenungsson E. Sci Rep. 2016 Oct 25;6:36025
- A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
  Pettersson S, Svenungsson E, Gustafsson J, Möller S, Gunnarsson I, Welin Henriksson E.
  Scand J Rheumatol. 2017 Mar 15:1-10.
- Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
  Gustafsson JT, Herlitz Lindberg M, Gunnarsson I, Pettersson S, Elvin K, Öhrvik J, Larsson A, Jensen-Urstad K, Svenungsson E.
  PLoS One. 2017 Apr 17;12(4)
- IFN- λ 1 with Th17 axis cytokines and IFN- α define different subsets in systemic lupus erythematosus
  Oke V, Brauner S, Larsson A, Gustafsson J, Zickert A, Gunnarsson I, Svenungsson E.
  Arthritis Res Ther. 2017 Jun 15;19(1): 1344-7.
- Depressed serum IgM levels in SLE are restricted to defined subgroups.
  Grönwall C, Hardt U, Gustafsson JT, Elvin K, Jensen-Urstad K, Kvarnström M, Grosso G, Rönnelid J, Padykov L, Gunnarsson I, Silverman GJ, Svenungsson E. Clin Immunol. 2017 Oct;183:304-315
- Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis
  Wigren M, Svenungsson E, Mattisson IY, Gustafsson JT, Gunnarsson I, Zickert A, Elvin K, Jensen-Urstad K, Bengtsson A, Gullstrand B, Fredrikson GN, Nilsson J. Atherosclerosis. 2018 Mar;270:1-7.
- TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
  Idborg H, Eketjäll S, Pettersson S, Gustafsson JT, Zickert A, Kvarnström M, Oke V, Jakobsson PJ, Gunnarsson I, Svenungsson E. Lupus Sci Med. 2018 Jun 4;5(1)
Μέλος Εταιριών, Συντακτικής Επιτροπής Περιοδικών
- Ελληνική Ρευματολογική Εταιρεία, Μέλος
- Ιατρικός Σύλλογος Αθηνών. Μέλος με Ειδικότητα Ρευματολογία
- Swedish National Board of Health and Welfare, Specialist Registry, Rheumatology
- Swedish National Board of Health and Welfare, Professional Medical License
- Swedish Medical Association, Membership
Έρευνα
- Research Fellow, Department of Rheumatology, Karolinska University Hospital, Sweden